首页> 外国专利> CU EDTA/ASCORBIC ACID CONTRACEPTIVE

CU EDTA/ASCORBIC ACID CONTRACEPTIVE

机译:EDTA /抗坏血酸避孕药

摘要

A contraceptive method for living animals (including human beings) where a cap or disc (10) of cellular material provides an inert carrier matrix to support contraceptive preparations, the cap or disc (10) being engageable with the external os of the cervical canal. The contraceptive preparation which includes divalent and/or trivalent metal cations and L-ascorbic acid and/or neuraminidase cause the cervical mucus which comes into contact with the dose to change from an open cellular structure found at mid cycle of the menstrual period to a closed cellular structure which forms an impenetrable barrier for spermatozoa. The contraceptive preparation can further include asialoglycoprotein as an acceptor for spermatozoal sialic acid to prevent penetration and fertilization of ova by the spermatozoa. A subsidiary contraceptve property of the preparations is that they may be spermotoxic causing reformation of seminal plasma to trap the spermatozoa leading to their death due to acidity of the vagina (16).
机译:一种用于活体动物(包括人)的避孕方法,其中细胞材料的盖子或圆盘(10)提供惰性载体基质来支撑避孕制剂,该盖子或圆盘(10)可与子宫颈管的外部开口接合。包含二价和/或三价金属阳离子和L-抗坏血酸和/或神经氨酸酶的避孕制剂会导致与剂量接触的宫颈粘液从在月经中期发现的开放性细胞结构变为闭合形成精子不可穿透屏障的细胞结构。避孕制剂可以进一步包括去唾液酸糖蛋白作为精子唾液酸的受体,以防止精子渗透和受精。制剂的辅助避孕性能是它们可能具有精子毒性,导致精浆重整以捕获精子,导致其因阴道酸度而死亡(16)。

著录项

  • 公开/公告号AU588807B2

    专利类型

  • 公开/公告日1989-09-28

    原文格式PDF

  • 申请/专利权人 UNIVERSITY OF QUEENSLAND;

    申请/专利号AU19850042917

  • 发明设计人 DR. BRIAN DAUNTER;

    申请日1985-04-17

  • 分类号A61F5/46;

  • 国家 AU

  • 入库时间 2022-08-22 06:35:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号